JPMorgan Chase & Co. Has $1.68 Billion Holdings in Cencora, Inc. $COR

JPMorgan Chase & Co. grew its stake in Cencora, Inc. (NYSE:COR) by 6.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,982,557 shares of the company’s stock after buying an additional 304,760 shares during the quarter. JPMorgan Chase & Co. owned 2.57% of Cencora worth $1,682,859,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. AustralianSuper Pty Ltd acquired a new position in Cencora during the third quarter worth $26,191,000. Chilton Investment Co. Inc. acquired a new position in Cencora during the third quarter worth $459,000. Advisors Asset Management Inc. boosted its holdings in Cencora by 40.3% during the third quarter. Advisors Asset Management Inc. now owns 17,302 shares of the company’s stock worth $5,407,000 after purchasing an additional 4,973 shares during the last quarter. Lansforsakringar Fondforvaltning AB publ boosted its holdings in Cencora by 5.4% during the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock worth $18,831,000 after purchasing an additional 3,073 shares during the last quarter. Finally, Rhumbline Advisers boosted its holdings in Cencora by 4.0% during the third quarter. Rhumbline Advisers now owns 430,150 shares of the company’s stock worth $134,435,000 after purchasing an additional 16,539 shares during the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on COR. Wells Fargo & Company reduced their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Barclays upped their price target on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Citigroup dropped their price target on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Evercore set a $360.00 price target on shares of Cencora in a research report on Wednesday, April 8th. Finally, Morgan Stanley set a $342.00 price target on shares of Cencora in a research report on Friday, May 8th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Cencora presently has an average rating of “Moderate Buy” and a consensus target price of $380.25.

Cencora Stock Performance

NYSE COR opened at $274.04 on Tuesday. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The firm’s fifty day moving average price is $291.82 and its two-hundred day moving average price is $329.69. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The firm has a market capitalization of $53.32 billion, a P/E ratio of 21.02, a price-to-earnings-growth ratio of 1.48 and a beta of 0.59.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. During the same period last year, the company posted $4.42 earnings per share. The business’s revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts anticipate that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. Cencora’s dividend payout ratio is presently 18.40%.

Cencora declared that its Board of Directors has authorized a stock buyback plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its shares are undervalued.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.